An observational study in Measles, sponsored by Marmara University. Completed at 2 sites in Turkey. Open to participants aged 1 Month to 18 Years. Per ClinicalTrials.gov, last updated 2024-11-21.
Sponsored by Marmara University · Observational
Measles, can be prevented and eliminated by vaccination, is a highly contagious viral disease that can lead to serious complications, disability, and death. As a result of the World Health Organization (WHO) and United Nations International Children's Emergency Fund (UNICEF) strategic plans, the annual global incidence of measles decreased by 75% over the period 2000-2015, and the estimated global mortality rate fell by 73%. For the current 2019 period, the European and the Eastern Mediterranean Region has recorded respectively more than two-fold and 1.5-fold increase in reported measles cases. As it is known, no specific antiviral treatment exists for the measles virus therefore, vaccination is still the most effective method of preventing disease.
The aim of this study was to evaluate the measles cases in districts where the refugees live quite intensely.
Measles, can be prevented and eliminated by vaccination, is a highly contagious viral disease that can lead to serious complications, disability, and death. As a result of the World Health Organization (WHO) and United Nations International Children's Emergency Fund (UNICEF) strategic plans, the annual global incidence of measles decreased by 75% over the period 2000-2015, and the estimated global mortality rate fell by 73%. For the current 2019 period, the European and the Eastern Mediterranean Region has recorded respectively more than two-fold and 1.5-fold increase in reported measles cases. As it is known, no specific antiviral treatment exists for the measles virus therefore, vaccination is still the most effective method of preventing disease.
The aim of this study was to evaluate the measles cases in districts where the refugees live quite intensely.
This retrospective study was consecutively enrolled children who were considered as suspicious measles case according to with clinical features and attended in Esenler Gynecology and Pediatrics Hospital Pediatric Clinic between 01 January-30 June 2019.
134 studies on the registry are indexed under Measles; 17 are open to participants now.
This study's enrollment of 40 is below the median of 282 across 26 observational studies indexed under Measles.
Browse Measles studies →Marmara University is the lead sponsor of 599 studies on the registry; 138 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Measles case according to with clinical features and attended Pediatric Clinic between 01 January-30 June 2019
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Evaluate the effect of measles vaccination status on symptom duration
compare the groups symptom durations (day) who fully, partly or not vaccinated
Time frame: baseline
Evaluate the effect of vitamin A treatment on symptom duration
compare the groups symptom durations (day) who get or not get vitamin A treatment
Time frame: in the first month after the first symptom observed
Evaluate the effect of measles vaccination status on leucocyte count
compare the groups leucocyte count who fully, partly or not vaccinated
Time frame: baseline
Evaluate the effect of vitamin A treatment on leucocyte count
compare the groups leucocyte count who get or not get vitamin A treatment
Time frame: baseline
Evaluate the effect of measles vaccination status on cost of measles cases
compare the groups costs (Turkish Lira) who fully, partly or not vaccinated
Time frame: in the first month after the first symptom observed
Evaluate the effect of vitamin A treatment on cost of measles cases
compare the groups costs (Turkish Lira) who get or not get vitamin A treatment
Time frame: in the first month after the first symptom observed
Plan to share: Undecided — Availability of data and material: When needed, all data can be shared with the consent of the participants.
This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.